Published in Transpl Int on April 01, 1988
Liver transplantation (1). N Engl J Med (1989) 4.53
Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg (1990) 2.37
Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83
Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg (1990) 1.64
Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg (1990) 1.50
Graft loss after pediatric liver transplantation. Ann Surg (2002) 0.85
Pre- and post-transplant assessment of liver function in paediatric liver transplantation. Eur J Pediatr (1992) 0.79
Russell Strong and the history of reduced-size liver transplantation. World J Surg (2009) 0.75
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet (1994) 3.24
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A (1998) 2.17
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy. Pediatr Transplant (2003) 2.03
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology (2001) 1.99
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol (1998) 1.77
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation (1996) 1.61
In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation (1995) 1.61
Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg (1996) 1.50
Hepatoblastoma in a child with progressive familial intrahepatic cholestasis. Pediatr Transplant (2005) 1.48
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology (1998) 1.46
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43
[Prolonged intensive care stay after abdominal surgery interventions with special reference to quality of life, occupational rehabilitation and economics]. Chirurg (1997) 1.42
[What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases]. Langenbecks Arch Chir (1995) 1.41
First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplant (2001) 1.40
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39
Application of adjusted survival curves to renal transplant data. Methods Inf Med (1992) 1.39
[Multivariate analysis of prognostic factors after resection of ductal pancreatic carcinomas]. Langenbecks Arch Chir (1995) 1.38
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg (1991) 1.31
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30
Long-term results after surgery for acute mesenteric ischemia. Surgery (1997) 1.26
Patterns of donor-type microchimerism after heart transplantation. Lancet (1994) 1.25
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Liver transplantation. Transplant Proc (1987) 1.23
Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23
Results of portal thrombectomy and splanchnic thrombolysis for the surgical management of acute mesentericoportal thrombosis. Br J Surg (1997) 1.22
Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21
Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation (1993) 1.19
Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation (1988) 1.16
Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery (1990) 1.16
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today (1994) 1.14
Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation (1991) 1.13
Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg (1995) 1.13
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Total hepatectomy as temporary approach to acute hepatic or primary graft failure. Transplant Proc (1988) 1.13
Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13
Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg (1989) 1.12
Living donor for liver transplantation. Hepatology (1994) 1.11
Living related liver transplantation: 36 cases at the University of Hamburg. Transplant Proc (1994) 1.10
Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch (1997) 1.10
Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc (1987) 1.10
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation (1996) 1.08
Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc (1987) 1.07
Selection of the living liver donor. Transplantation (1995) 1.07
Is there still a need for living-related liver transplantation in children? Ann Surg (2001) 1.04
Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem (1987) 1.04
Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation (1993) 1.04
Persistence of donor lymphocytes in liver allograft recipients. Transplantation (1993) 1.02
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. Transplant Proc (1991) 1.00
Results of biliary reconstruction after liver transplantation. Transplant Proc (1984) 1.00
Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology (1993) 1.00
Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology (1999) 0.99
Analysis of biliary complications following orthotopic liver transplantation. Transplant Proc (1989) 0.99
Squamous cell carcinoma of the liver originating from a solitary non-parasitic cyst case report and review of the literature. HPB Surg (1996) 0.99
Hepatic retransplantation: the Hannover experience of two decades. Transplant Proc (1993) 0.99
Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem Pharmacol (1997) 0.98
Detection and monitoring of intracranial pressure dysregulation in liver failure by ultrasound. Transplantation (2000) 0.98
Benign schwannoma of the liver with cystic changes misinterpreted as hydatid disease. Hepatogastroenterology (1999) 0.98
Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation (1990) 0.97
Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther Drug Monit (1990) 0.97
Total hepatectomy and liver transplantation: a life-saving procedure in patients with severe hepatic trauma. Br J Surg (1995) 0.96
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transpl Surg (1996) 0.95
Production and effect of heterologous anti-canine lymphocyte serum. Surgery (1967) 0.95
Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation. Transplantation (2001) 0.95
Hepatitis B virus mutations in the pre-S genome before and after liver transplantation. Hepatology (1996) 0.94
[Antilymphocyte serum therapy in human autoimmune diseases]. Klin Wochenschr (1968) 0.94
Fourth component of complement (C4) polymorphism in human orthotopic liver transplantation. Transplantation (1985) 0.94
Ex-vivo resection techniques in tissue-preserving surgery for liver malignancies. Langenbecks Arch Surg (2000) 0.93
[Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia]. Klin Wochenschr (1968) 0.93
Vascular problems in liver transplantation. Transplant Proc (1987) 0.93
Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation. Transplant Proc (1994) 0.93
Intensive care management after pediatric liver transplantation: a single-center experience. Pediatr Transplant (2000) 0.92
Kidney transplanted children come of age. Kidney Int (1999) 0.92
Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology (1996) 0.92
Management of severe hepatic trauma by two-stage total hepatectomy and subsequent liver transplantation. Surgery (1991) 0.91
Extramedullary erythropoiesis in human liver grafts. Hepatology (1995) 0.91
Disseminated islands of gastric mucosa in jejunum and ileum detected by technetium-99m-pertechnetate scintigraphy. J Nucl Med (1997) 0.90
Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology (1998) 0.90